-
Something wrong with this record ?
Recommendations for the management of patients with immune-mediated kidney disease during the severe acute respiratory syndrome coronavirus 2 pandemic
HJ. Anders, A. Bruchfeld, GM. Fernandez Juarez, J. Floege, D. Goumenos, K. Turkmen, C. van Kooten, V. Tesar, M. Segelmark,
Language English Country Great Britain
Document type Journal Article, Practice Guideline, Research Support, Non-U.S. Gov't
NLK
Free Medical Journals
from 1996 to 1 year ago
Open Access Digital Library
from 1996-01-01
PubMed
32445573
DOI
10.1093/ndt/gfaa112
Knihovny.cz E-resources
- MeSH
- Antiviral Agents MeSH
- Betacoronavirus MeSH
- Renal Dialysis MeSH
- Risk Assessment MeSH
- Immunosuppressive Agents therapeutic use MeSH
- Coronavirus Infections complications immunology therapy MeSH
- Humans MeSH
- Nephrology standards MeSH
- Kidney Diseases complications immunology therapy MeSH
- Pandemics MeSH
- Retrospective Studies MeSH
- Risk Factors MeSH
- Societies, Medical MeSH
- Pneumonia, Viral complications immunology therapy MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Practice Guideline MeSH
- Geographicals
- Europe MeSH
The coronavirus disease 2019 (COVID-19) pandemic has created major challenges for all countries around the globe. Retrospective studies have identified hypertension, cardiovascular disease, diabetes and older age as risk factors for high morbidity and mortality from COVID-19. There is a general concern that patients with immune-mediated kidney diseases, namely those on immunosuppressive therapies and/or those with more advanced kidney failure, could particularly be at risk for adverse outcomes due to a compromised antiviral immunity. Uncertainties exist on how management routines should be reorganized to minimize the risk of severe acute respiratory syndrome coronavirus 2 infection and what measures are necessary for infected patients. The aim of the present review of the Immunonephrology Working Group of the European Renal Association-European Dialysis and Transplant Association is to provide recommendations for the management of patients with immune-mediated kidney diseases based on the available evidence, similar circumstances with other infectious organisms and expert opinions from across Europe. Such recommendations may help to minimize the risk of encountering COVID-19 or developing complications during COVID-19 in patients with immune-mediated kidney disease.
Department of Nephrology and Renal Transplantation Patras University Hospital Patras Greece
Department of Nephrology Hospital Universitario Fundación Alcorcón Alcorcón Spain
Division of Nephrology Department of Internal Medicine Necmettin Erbakan University Konya Turkey
Division of Nephrology Medizinische Klinik und Poliklinik 4 Klinikum der Universität Munich Germany
Division of Nephrology RWTH Aachen University Hospital Aachen Germany
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20024989
- 003
- CZ-PrNML
- 005
- 20201222153633.0
- 007
- ta
- 008
- 201125s2020 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/ndt/gfaa112 $2 doi
- 035 __
- $a (PubMed)32445573
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Anders, Hans-Joachim $u Division of Nephrology, Medizinische Klinik und Poliklinik IV, Klinikum der Universität, Munich, Germany.
- 245 10
- $a Recommendations for the management of patients with immune-mediated kidney disease during the severe acute respiratory syndrome coronavirus 2 pandemic / $c HJ. Anders, A. Bruchfeld, GM. Fernandez Juarez, J. Floege, D. Goumenos, K. Turkmen, C. van Kooten, V. Tesar, M. Segelmark,
- 520 9_
- $a The coronavirus disease 2019 (COVID-19) pandemic has created major challenges for all countries around the globe. Retrospective studies have identified hypertension, cardiovascular disease, diabetes and older age as risk factors for high morbidity and mortality from COVID-19. There is a general concern that patients with immune-mediated kidney diseases, namely those on immunosuppressive therapies and/or those with more advanced kidney failure, could particularly be at risk for adverse outcomes due to a compromised antiviral immunity. Uncertainties exist on how management routines should be reorganized to minimize the risk of severe acute respiratory syndrome coronavirus 2 infection and what measures are necessary for infected patients. The aim of the present review of the Immunonephrology Working Group of the European Renal Association-European Dialysis and Transplant Association is to provide recommendations for the management of patients with immune-mediated kidney diseases based on the available evidence, similar circumstances with other infectious organisms and expert opinions from across Europe. Such recommendations may help to minimize the risk of encountering COVID-19 or developing complications during COVID-19 in patients with immune-mediated kidney disease.
- 650 _2
- $a antivirové látky $7 D000998
- 650 _2
- $a Betacoronavirus $7 D000073640
- 650 _2
- $a koronavirové infekce $x komplikace $x imunologie $x terapie $7 D018352
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunosupresiva $x terapeutické užití $7 D007166
- 650 _2
- $a nemoci ledvin $x komplikace $x imunologie $x terapie $7 D007674
- 650 _2
- $a nefrologie $x normy $7 D009398
- 650 _2
- $a pandemie $7 D058873
- 650 _2
- $a virová pneumonie $x komplikace $x imunologie $x terapie $7 D011024
- 650 _2
- $a dialýza ledvin $7 D006435
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a hodnocení rizik $7 D018570
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a společnosti lékařské $7 D012955
- 651 _2
- $a Evropa $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a směrnice pro lékařskou praxi $7 D017065
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Bruchfeld, Annette $u Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden. Division of Diagnostics and Specialist Medicine, Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
- 700 1_
- $a Fernandez Juarez, Gema Maria $u Department of Nephrology, Hospital Universitario Fundación Alcorcón, Alcorcón, Spain.
- 700 1_
- $a Floege, Jürgen $u Division of Nephrology, RWTH Aachen University Hospital, Aachen, Germany.
- 700 1_
- $a Goumenos, Dimitrios $u Department of Nephrology and Renal Transplantation, Patras University Hospital, Patras, Greece.
- 700 1_
- $a Turkmen, Kultigin $u Division of Nephrology, Department of Internal Medicine, Necmettin Erbakan University, Konya, Turkey.
- 700 1_
- $a van Kooten, Cees $u Division of Nephrology and Transplant Medicine, Department of Medicine, Leiden University Medical Center, Leiden, The Netherlands.
- 700 1_
- $a Tesar, Vladimir $u Department of Nephrology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Segelmark, Mårten $u Division of Diagnostics and Specialist Medicine, Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden. Division of Nephrology, Department of Clinical Sciences Lund, Lund University and Skåne University Hospital, Lund, Sweden.
- 773 0_
- $w MED00010288 $t Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association $x 1460-2385 $g Roč. 35, č. 6 (2020), s. 920-925
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32445573 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201222153629 $b ABA008
- 999 __
- $a ok $b bmc $g 1599134 $s 1115675
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 35 $c 6 $d 920-925 $e 20200601 $i 1460-2385 $m Nephrology, dialysis, transplantation $n Nephrol Dial Transplant $x MED00010288
- LZP __
- $a Pubmed-20201125